Dr Reddys Laboratories (RDY) Total Current Liabilities (2017 - 2026)
Dr Reddys Laboratories has reported Total Current Liabilities over the past 10 years, most recently at $1.8 billion for Q1 2026.
- For Q1 2026, Total Current Liabilities rose 21.73% year-over-year to $1.8 billion; the TTM value through Mar 2026 reached $1.8 billion, up 21.73%, while the annual FY2026 figure was $1.8 billion, 20.04% up from the prior year.
- Total Current Liabilities for Q1 2026 was $1.8 billion at Dr Reddys Laboratories, up from $1.5 billion in the prior quarter.
- Over five years, Total Current Liabilities peaked at $1.8 billion in Q1 2026 and troughed at $20.0 million in Q1 2023.
- A 5-year average of $908.6 million and a median of $1.2 billion in 2024 define the central range for Total Current Liabilities.
- Biggest five-year swings in Total Current Liabilities: crashed 43.56% in 2022 and later surged 5668.54% in 2024.
- Year by year, Total Current Liabilities stood at $27.7 million in 2022, then dropped by 27.7% to $20.0 million in 2023, then surged by 5668.54% to $1.2 billion in 2024, then surged by 30.21% to $1.5 billion in 2025, then rose by 21.73% to $1.8 billion in 2026.
- Business Quant data shows Total Current Liabilities for RDY at $1.8 billion in Q1 2026, $1.5 billion in Q1 2025, and $1.2 billion in Q1 2024.